RecruitingNot ApplicableNCT06339996

Male Supplements for Sperm Quality and Aging

To Investigate Supplements for Improving Male Sperm Quality and Combating Aging


Sponsor

Kaohsiung Veterans General Hospital.

Enrollment

50 participants

Start Date

Mar 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.


Eligibility

Sex: MALEMin Age: 30 YearsMax Age: 50 Years

Inclusion Criteria2

  • Not meet the criteria of the 6th edition of the WHO manual for human semen analysis
  • BMI:18-30 kg/m2

Exclusion Criteria5

  • Azoospermia
  • Varicocele
  • Chromosome anomaly
  • Malignancy
  • Using hormone therapy or supplements in recent 3 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTMale supplement

Participants will be administered supplements for a three-month treatment period


Locations(1)

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06339996


Related Trials